Drug recall D-0871-2023

Class III Terminated reported Jun 21, 2023

Product

Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Lots and codes

Lots: X220317A and X220318A, exp. date 09/25

Recall details

Recalling firm
Amring Pharmaceuticals Inc, Berwyn, PA
Quantity
48,989 bottles
Distribution
Nationwide in the USA.
Type
Voluntary: Firm initiated
Recall initiated
June 12, 2023
Terminated
May 29, 2024

Related products